Search research articles
Contact Us
Filters
Showing results (61-70 of 135) with videos related to
Page
of 14
Sort By:
The International Journal on Drug Policy
|
December 6, 2021
Experiences with substance use disorder treatment during the COVID-19 pandemic: Findings from a multistate survey
Brendan Saloner, Noa Krawczyk, Keisha Solomon, et al.
Journal of Addictive Diseases
|
August 25, 2020
Assessing perceptions about medications for opioid use disorder and Naloxone on Twitter
Babak Tofighi, Omar El Shahawy, Andrew Segoshi, et al.
Drug and Alcohol Dependence
|
January 28, 2021
Medications for opioid use disorder among American Indians and Alaska natives: Availability and use across a national sample
Noa Krawczyk, Brady Garrett, N Jia Ahmad, et al.
Journal of Substance Use and Addiction Treatment
|
October 23, 2024
Client and program-level factors associated with planned use of medications for opioid use disorder in specialty substance use treatment programs: Evidence from linked administrative data and survey data
Kenneth A Feder, Yuzhong Li, Kathryn N Burke, et al.
Journal of Substance Use and Addiction Treatment
|
April 29, 2025
Integration of harm reduction principles and practices within specialty substance use treatment programs in New Jersey: A qualitative study of program leadership
Valerie S Ganetsky, Kenneth A Feder, Kathryn N Burke, et al.
Journal of Substance Use and Addiction Treatment
|
May 1, 2025
Use of harm reduction practices by state-licensed specialty substance use treatment programs
Isha K Desai, Kathryn Burke, Yuzhong Li, et al.
The International Journal on Drug Policy
|
February 9, 2021
"How will I get my next week's script?" Reactions of Reddit opioid forum users to changes in treatment access in the early months of the coronavirus pandemic
Noa Krawczyk, Amanda M Bunting, David Frank, et al.
Journal of Substance Use and Addiction Treatment
|
March 18, 2024
Barriers and facilitators to use of buprenorphine in state-licensed specialty substance use treatment programs: A survey of program leadership
Kathryn N Burke, Noa Krawczyk, Yuzhong Li, et al.
Journal of Addiction Medicine
|
February 15, 2022
Shifting Medication Treatment Practices in the COVID-19 Pandemic: A Statewide Survey of Pennsylvania Opioid Treatment Programs
Noa Krawczyk, Hannah Maniates, Eric Hulsey, et al.
Addiction (Abingdon, England)
|
August 5, 2024
Comparative effectiveness of extended-release naltrexone and sublingual buprenorphine for treatment of opioid use disorder among Medicaid patients
Rachael K Ross, Edward V Nunes, Mark Olfson, et al.
Page
of 14
Search research articles
Search
Showing results (61-70 of 135) with videos related to
Sort By:
Page
of 14
The International Journal on Drug Policy
|
December 6, 2021
Experiences with substance use disorder treatment during the COVID-19 pandemic: Findings from a multistate survey
Brendan Saloner, Noa Krawczyk, Keisha Solomon, et al.
Journal of Addictive Diseases
|
August 25, 2020
Assessing perceptions about medications for opioid use disorder and Naloxone on Twitter
Babak Tofighi, Omar El Shahawy, Andrew Segoshi, et al.
Drug and Alcohol Dependence
|
January 28, 2021
Medications for opioid use disorder among American Indians and Alaska natives: Availability and use across a national sample
Noa Krawczyk, Brady Garrett, N Jia Ahmad, et al.
Journal of Substance Use and Addiction Treatment
|
October 23, 2024
Client and program-level factors associated with planned use of medications for opioid use disorder in specialty substance use treatment programs: Evidence from linked administrative data and survey data
Kenneth A Feder, Yuzhong Li, Kathryn N Burke, et al.
Journal of Substance Use and Addiction Treatment
|
April 29, 2025
Integration of harm reduction principles and practices within specialty substance use treatment programs in New Jersey: A qualitative study of program leadership
Valerie S Ganetsky, Kenneth A Feder, Kathryn N Burke, et al.
Journal of Substance Use and Addiction Treatment
|
May 1, 2025
Use of harm reduction practices by state-licensed specialty substance use treatment programs
Isha K Desai, Kathryn Burke, Yuzhong Li, et al.
The International Journal on Drug Policy
|
February 9, 2021
"How will I get my next week's script?" Reactions of Reddit opioid forum users to changes in treatment access in the early months of the coronavirus pandemic
Noa Krawczyk, Amanda M Bunting, David Frank, et al.
Journal of Substance Use and Addiction Treatment
|
March 18, 2024
Barriers and facilitators to use of buprenorphine in state-licensed specialty substance use treatment programs: A survey of program leadership
Kathryn N Burke, Noa Krawczyk, Yuzhong Li, et al.
Journal of Addiction Medicine
|
February 15, 2022
Shifting Medication Treatment Practices in the COVID-19 Pandemic: A Statewide Survey of Pennsylvania Opioid Treatment Programs
Noa Krawczyk, Hannah Maniates, Eric Hulsey, et al.
Addiction (Abingdon, England)
|
August 5, 2024
Comparative effectiveness of extended-release naltrexone and sublingual buprenorphine for treatment of opioid use disorder among Medicaid patients
Rachael K Ross, Edward V Nunes, Mark Olfson, et al.
Page
of 14